Literatur
Aiken, C., and Trono, D. (1995).
Nef stimulates human immunodeficiency virus type 1 proviral DNA synthesis. J Virol 69, 5048-5056.
Anest, V., Hanson, J. L., Cogswell, P. C., Steinbrecher, K. A., Strahl, B. D., and Baldwin, A. S. (2003).
A nucleosomal function for IkappaB kinase-alpha in NF-kappaB-dependent gene expression. Nature 423, 659-663.
Baur, A. S., Sass, G., Laffert, B., Willbold, D., Cheng-Mayer, C., and Peterlin, B. M. (1997).
The N-terminus of Nef from HIV-1/SIV associates with a protein complex containing Lck and a serine kinase. Immunity 6, 283-291.
Baur, A. S., Sawai, E. T., Dazin, P., Fantl, W. J., Cheng-Mayer, C., and Peterlin, B. M. (1994).
HIV-1 Nef leads to inhibition or activation of T cells depending on its intracellular localization. Immunity 1, 373-384.
Fackler, O. T., Luo, W., Geyer, M., Alberts, A. S., and Peterlin, B. M. (1999).
Activation of Vav by Nef induces cytoskeletal rearrangements and downstream effector functions. Mol Cell 3, 729-739.
Garcia, J. V., and Miller, A. D. (1991).
Serine phosphorylation-independent downregulation of cell-surface CD4 by nef. Nature 350, 508-511.
Hanna, Z., Kay, D. G., Rebai, N., Guimond, A., Jothy, S., and Jolicoeur, P. (1998).
Nef harbors a major determinant of pathogenicity for an AIDS-like disease induced by HIV-1 in transgenic mice. Cell 95, 163-175.
Hoberg, J. E., Popko, A. E., Ramsey, C. S., and Mayo, M. W. (2006).
IkappaB kinase alpha-mediated derepression of SMRT potentiates acetylation of RelA/p65 by p300. Mol Cell Biol 26, 457-471.
Hoberg, J. E., Yeung, F., and Mayo, M. W. (2004).
SMRT derepression by the IkappaB kinase alpha: a prerequisite to NF-kappaB transcription and survival. Mol Cell 16, 245-255.
Kestler, H. W., 3rd, Ringler, D. J., Mori, K., Panicali, D. L., Sehgal, P. K., Daniel, M. D., and Desrosiers, R. C. (1991).
Importance of the nef gene for maintenance of high virus loads and for development of AIDS. Cell 65, 651-662.
Kirchhoff, F., Greenough, T. C., Brettler, D. B., Sullivan, J. L., and Desrosiers, R. C. (1995).
Brief report: absence of intact nef sequences in a long-term survivor with nonprogressive HIV-1 infection. N Engl J Med 332, 228-232.
Lawrence, T., Bebien, M., Liu, G. Y., Nizet, V., and Karin, M. (2005).
IKKalpha limits macrophage NF-kappaB activation and contributes to the resolution of inflammation. Nature 434, 1138-1143.
Liu, B., Yang, Y., Chernishof, V., Loo, R. R., Jang, H., Tahk, S., Yang, R., Mink, S., Shultz, D., Bellone, C. J., et al. (2007).
Proinflammatory stimuli induce IKKalpha-mediated phosphorylation of PIAS1 to restrict inflammation and immunity. Cell 129,903-914.
Schwartz, O., Marechal, V., Danos, O., and Heard, J. M. (1995).
Human immunodeficiency virus type 1 Nef increases the efficiency of reverse transcription in the infected cell. J Virol 69, 4053-4059.
Schwartz, O., Marechal, V., Le Gall, S., Lemonnier, F., and Heard, J. M. (1996).
Endocytosis of major histocompatibility complex class I molecules is induced by the HIV-1 Nef protein. Nat Med 2, 338-342.
Su, I. H., Dobenecker, M. W., Dickinson, E., Oser, M., Basavaraj, A., Marqueron, R., Viale, A., Reinberg, D., Wulfing, C., and Tarakhovsky, A. (2005).
Polycomb group protein ezh2 controls actin polymerization and cell signaling. Cell 121, 425-436.
Wang, J. K., Kiyokawa, E., Verdin, E., and Trono, D. (2000).
The Nef protein of HIV-1 associates with rafts and primes T cells for activation. Proc Natl Acad Sci U S A 97, 394-399.
Xu, X. N., Laffert, B., Screaton, G. R., Kraft, M., Wolf, D., Kolanus, W., Mongkolsapay, J., McMichael, A. J., and Baur, A. S. (1999).
Induction of Fas ligand expression by HIV involves the interaction of Nef with the T cell receptor zeta chain. J Exp Med 189, 1489-1496.
Yamamoto, Y., Verma, U. N., Prajapati, S., Kwak, Y. T., and Gaynor, R. B. (2003).
Histone H3 phosphorylation by IKK-alpha is critical for cytokine-induced gene expression. Nature 423, 655-659
Seminare
24.05.2012
LPS recognition and signaling in mast cells: it´s hip to be square
Univ.-Prof. Michael Huber
Institut für Biochemie und Molekularbiologie
Universitätsklinikum Aachen
30.05.2012
Quantitative proteomics: from regulatory T cells to cellular programming
Dr. Markus Feuerer
DKFZ Heidelberg
Dr. Jeroen Krijgsveld
EMBL Heidelberg